Drug Monitoring, Buprenorphine, with Confirmation, includes Naloxone, Urine
Test Code
39373
80307
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Clinical Significance
Drug Monitoring, Buprenorphine, with Confirmation, includes Naloxone, Urine - Patients treated with buprenorphine-naloxone co-formulation will demonstrate both naloxone and buprenorphine/norbuprenorphine drug analysis. Naloxone is not detected with buprenorphine-only use.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
If you require medMATCH for this order code, you must also order code 39158 - Prescribed Drugs, medMATCH®. If 39158 is ordered, all Drug Monitoring order codes will be treated as medMATCH.
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Buprenorphine drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80348, 80362; HCPCS: G0480).
Confirmation includes the following analytes: Buprenorphine, Norbuprenorphine, Naloxone
If this test code is not ordered with 39158, all medMATCH result codes will be DNR’d.
.
Initial screen of the Buprenorphine drug class. If screen is positive, a confirmation will be performed at an additional charge (CPT code(s): 80348, 80362; HCPCS: G0480).
Confirmation includes the following analytes: Buprenorphine, Norbuprenorphine, Naloxone
Methodology
Screen: Immunoassay (IA) • Confirmation: Mass Spectrometry (MS)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range(s)
| Buprenorphine | <5 ng/mL |
| Buprenorphine | <2 ng/mL |
| Norbuprenorphine | <2 ng/mL |
| Naloxone | <2 ng/mL |
Alternative Name(s)
Naloxone,Suboxone®,Pain Management,Prescription Drug Monitoring
Preferred Specimen(s)
20 mL urine
Alternative Specimen(s)
Urine collected in urine collection container
Minimum Volume
7 mL
Transport Container
Clinical drug test transport vial
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 14 days
- Frozen: 30 days
Reject Criteria
Preserved samples
Setup Schedule
20 mL urine
Urine collected in urine collection container
7 mL
Clinical drug test transport vial
Room temperature
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Preserved samples